This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.Need a new registration confirmation email? Click here

Cardinal Health Reaches New 52-Week High (CAH)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK (
TheStreet) --
Cardinal Health (NYSE:
CAH) hit a new 52-week high Tuesday as it is currently trading at $46.95, above its previous 52-week high of $46.88 with 75,726 shares traded as of 9:35 a.m. ET. Average volume has been 2.5 million shares over the past 30 days.

Cardinal Health has a market cap of $15.77 billion and is part of the services sector and wholesale industry. Shares are up 12.4% year to date as of the close of trading on Monday.

Cardinal Health, Inc., a healthcare services company, provides pharmaceutical and medical products and services in the United States and internationally. The company operates in two segments, Pharmaceutical and Medical. The company has a P/E ratio of 14.1, below the S&P 500 P/E ratio of 17.7.

EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates Cardinal Health as a
buy. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, impressive record of earnings per share growth, compelling growth in net income, notable return on equity and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. You can view the full
Cardinal Health Ratings Report.